Cite

HARVARD Citation

    Gibofsky, A. et al. (2015). Low-dose SoluMatrix diclofenac: a review of safety across two Phase III studies in patients with acute and osteoarthritis pain. Expert opinion on drug safety. pp. 1327-1339. [Online]. 
  
Back to record